NXS 3.57% 14.5¢ next science limited

IPO - Next Science Limited, page-69

  1. 185 Posts.
    lightbulb Created with Sketch. 34

    From the report above.

    Globally, the chronic wound care market was estimated at US$13.7 billion in 2016.

    In the US, about 6.7 million people were believed to suffer from chronic wounds costing the country around US$50 billion a year to treat.

    “We see we can help reduce that expenditure everywhere if we can get our technology situated into the standard of care in wound care.”

    “We think we can take about 20-30% off the global cost of helping these patients.”


    Even based on the 2016 figures, Next Science can potentially save the globe over $4 billion in Chronic wound expenditure. Imagine the revenue that this will generate for NSX!.

 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
14.5¢
Change
0.005(3.57%)
Mkt cap ! $42.36M
Open High Low Value Volume
14.0¢ 15.0¢ 14.0¢ $41.4K 286.0K

Buyers (Bids)

No. Vol. Price($)
2 6800 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 46160 3
View Market Depth
Last trade - 15.44pm 31/10/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.